In this study, there was no significant correlationbetween VDR and CYP24A1 expression levelsand clinical findings, such as the level of physicaldisability in MS patients (according to the EDSScriterion) and disease duration. This evidence concerns the gene CYP24A1 and myeloid sarcoma.